# Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

> **NCT01377220** · PHASE2 · UNKNOWN · sponsor: **Commissariat A L'energie Atomique** · enrollment: 30 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** 11C-Choline

## Key facts

- **NCT ID:** NCT01377220
- **Lead sponsor:** Commissariat A L'energie Atomique
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2013-06
- **Final completion:** 2014-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377220, "Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01377220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
